TD Asset Management Inc Sells 115,200 Shares of BWX Technologies, Inc. $BWXT

TD Asset Management Inc decreased its stake in BWX Technologies, Inc. (NYSE:BWXT) by 35.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 212,600 shares of the technology company’s stock after selling 115,200 shares during the period. TD Asset Management Inc owned 0.23% of BWX Technologies worth $39,197,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of BWXT. Invesco Ltd. increased its position in shares of BWX Technologies by 139.0% during the 2nd quarter. Invesco Ltd. now owns 1,592,380 shares of the technology company’s stock worth $229,398,000 after purchasing an additional 926,117 shares during the last quarter. Artisan Partners Limited Partnership acquired a new stake in shares of BWX Technologies in the 2nd quarter valued at approximately $183,859,000. Massachusetts Financial Services Co. MA grew its stake in shares of BWX Technologies by 26.0% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,159,033 shares of the technology company’s stock valued at $213,691,000 after buying an additional 239,292 shares in the last quarter. Mawer Investment Management Ltd. increased its holdings in BWX Technologies by 15.6% during the second quarter. Mawer Investment Management Ltd. now owns 900,449 shares of the technology company’s stock worth $129,719,000 after buying an additional 121,498 shares during the last quarter. Finally, Raymond James Financial Inc. raised its position in BWX Technologies by 7.9% during the second quarter. Raymond James Financial Inc. now owns 707,602 shares of the technology company’s stock worth $101,937,000 after acquiring an additional 51,998 shares in the last quarter. Institutional investors own 94.39% of the company’s stock.

BWX Technologies Price Performance

Shares of NYSE BWXT opened at $205.55 on Friday. The firm has a market cap of $18.80 billion, a P/E ratio of 57.58, a price-to-earnings-growth ratio of 3.39 and a beta of 0.84. The business’s 50 day moving average is $198.41 and its 200-day moving average is $187.45. The company has a current ratio of 2.32, a quick ratio of 1.62 and a debt-to-equity ratio of 1.64. BWX Technologies, Inc. has a 1-year low of $84.21 and a 1-year high of $220.57.

BWX Technologies (NYSE:BWXT) last issued its quarterly earnings data on Monday, February 23rd. The technology company reported $1.08 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.17. BWX Technologies had a return on equity of 30.94% and a net margin of 10.28%.The firm had revenue of $885.84 million for the quarter, compared to analyst estimates of $837.47 million. During the same period in the prior year, the firm posted $0.92 EPS. The company’s revenue for the quarter was up 18.7% on a year-over-year basis. BWX Technologies has set its FY 2026 guidance at 4.550-4.700 EPS. Equities research analysts predict that BWX Technologies, Inc. will post 3.23 earnings per share for the current year.

BWX Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 27th. Stockholders of record on Wednesday, March 11th will be given a $0.27 dividend. The ex-dividend date is Wednesday, March 11th. This is a positive change from BWX Technologies’s previous quarterly dividend of $0.25. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.5%. BWX Technologies’s dividend payout ratio (DPR) is presently 28.01%.

Insider Buying and Selling

In other BWX Technologies news, Director Gerhard F. Burbach sold 1,983 shares of the firm’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $208.61, for a total transaction of $413,673.63. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $203.26, for a total value of $2,032,600.00. Following the completion of the transaction, the chief executive officer directly owned 177,594 shares of the company’s stock, valued at $36,097,756.44. This represents a 5.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.47% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on BWXT. Wall Street Zen downgraded shares of BWX Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings upgraded shares of BWX Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday. Bank of America boosted their price target on BWX Technologies from $220.00 to $230.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. BTIG Research upped their price objective on BWX Technologies from $225.00 to $235.00 and gave the company a “buy” rating in a research note on Thursday. Finally, CJS Securities raised BWX Technologies to a “strong-buy” rating in a research report on Friday, December 12th. Three analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, BWX Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $200.45.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.